MedPath

Continuous Versus Interval Walking Training in Patients With COPD - a Pilot Study

Not Applicable
Completed
Conditions
Chronic Obstructive Airway Disease
Registration Number
NCT02209207
Lead Sponsor
Schön Klinik Berchtesgadener Land
Brief Summary

This study will investigate the effects of interval walking training versus continuous walking training in patients with chronic obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized to one of the two intervention groups. All walking training sessions will be performed on the same treadmill. Walking intensity in the continuous walking group will be 60 percent of the average speed of the 6-minute walking test. Patients in the interval training group will perform high intensity intervals at 120% of the 6-minute walking test speed for 60 seconds alternating with 60 seconds of rest. The total exercise duration will be progressively increased from 10 to 32 minutes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • COPD stage III or IV according to the Global Initiative for chronic obstructive lung disease [GOLD]
  • stationary patient in the Schön Klinik Berchtesgadener Land
Exclusion Criteria
  • acute, severe exacerbation of COPD
  • failure to comply with study process

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
perceived exertion for dyspnea during walking trainingday 1 to 21

measured via modified Borg scale (0 to 10)

Secondary Outcome Measures
NameTimeMethod
6-minute walking testday 1 to 21

the best 6-minute walking test out of two tests on admission and at discharge will be taken

heart rate during walking trainingday 1 to 21
Oxygen saturation during walking trainingday 1 to 21

measured via pulse oximeter

perceived exertion for leg fatigue (Borg-scale)during three weeks of rehabilitation
Sit-to-stand-testday 1 to 21

5 repetitions of standing up and sitting down from a chair with crossed arms as quick as possible

fat free mass in kilogramday 1 to 21

measured via Bioimpedance Analysis

forced expiratory volume in 1 second (FEV1) in literday 1 to 21

measured by spirometry

36 item short-form health Survey (SF-36)day 1 to 21

questionnaire for disease unspecific quality of life

chronic respiratory questionnaire (CRQ)day 1 to 21

disease specific quality of life questionnaire

hospital anxiety and depression scale (HADS)day 1 to 21

questionnaire on symptoms of anxiety and depression

Trial Locations

Locations (1)

Schön Klinik Berchtesgadener Land

🇩🇪

Schönau am Königssee, Germany

Schön Klinik Berchtesgadener Land
🇩🇪Schönau am Königssee, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.